Quantcast

Latest Tuberculosis treatment Stories

2014-03-20 04:21:53

BEIJING and HILDEN, Germany, March 20, 2014 /PRNewswire/ -- - QuantiFERON-TB, the leading modern test for accurate diagnosis of latent tuberculosis infections, continues to grow rapidly around the world - Commercial launch of QuantiFERON-TB in China, where latent TB affects an estimated 41% of population, will support nationwide efforts to control TB - QIAGEN marks World TB Day 2014 on March 24 with QuantiFERON-TB...

2014-02-13 08:30:51

MOSCOW, February 13, 2014 /PRNewswire/ -- Russian and Korean biotech companies Infectex Ltd. [http://www.infectex.ru/?ln=en ] and Qurient Ltd. [http://maxwellbiotech.com ] have announced a license agreement granting Infectex exclusive rights to develop and commercialize Qurient's Tuberculosis-fighting drug Q203 in the Russian Federation, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan and Ukraine. (Logo:...

2014-02-04 12:27:12

Multi-year grant brings together non-profits, government, academia and the pharmaceutical industry to study pressing public health challenge TUCSON, Ariz., Feb. 4, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute, an independent, non-profit that catalyzes innovative ideas that accelerate the speed of drug and medical product development, today announced it has received a three-year grant from the Bill & Melinda Gates Foundation. The grant will be used to develop...

2014-01-28 23:04:15

Aim to Improve Care for HIV Patients in Irkutsk, Halt Growing Health Threat Charlottesville, VA (PRWEB) January 28, 2014 Researchers at the University of Virginia School of Medicine and colleagues in Russia are launching an ambitious effort to check the growing public health threat posed by drug-resistant tuberculosis, especially to people with HIV, in the Siberian city of Irkutsk. It’s a critically important mission, both for the people there and because of the risk that international...

2014-01-23 11:29:46

A major trial aiming to cut the rate of tuberculosis (TB) among South Africa's gold miners did not reduce the number of cases or deaths from the disease, according to a study published in the New England Journal of Medicine. Researchers from the London School of Hygiene & Tropical Medicine say that the results demonstrate the scale of the TB problem in South African gold mines, and highlight the need for a "combination prevention" approach to improve TB control. The TB epidemic in...

2013-11-19 23:30:30

With the current shortage of TB skin tests, customers can order TB blood testing from Request A Test as an alternative. Brecksville, OH (PRWEB) November 19, 2013 Request A Test, a leading national provider of direct to consumer lab testing, is currently offering the QuantiFERON Gold blood test for Tuberculosis (TB). A Recent shortage of materials needed to perform Tuberculosis skin tests has led to many people and companies not being able to get the testing they need. The Center for...

2013-10-31 23:34:25

Immunitor, Inc., a commercial stage company committed to developing oral therapeutic vaccines, today announced that its second Phase II trial of oral TB vaccine with heat-killed Mycobacterium vaccae (V7) was published in October issue of Immunotherapy journal. Vancouver, BC, Canada (PRWEB) October 31, 2013 This study is second of two Phase II trials run by Immunitor in Ukraine. The trial was conducted in 41 patients with pulmonary tuberculosis randomized into treatment (N=20) and placebo...

2013-10-23 23:20:34

Lauds Reduction in New Infections and Lowered Mortality Rate of TB; Urges More Aggressive Identification of Nearly 3 Million “Missed” New Cases of TB Annually and Greater Focus on More Virulent Strains of TB to Avert Public Health Crisis New York, NY (PRWEB) October 23, 2013 Today, the World Health Organization (WHO) released its Global Tuberculosis Report 2013. Ray Chambers, the UN Secretary-General’s Special Envoy for Financing the Health MDGs and for Malaria, acknowledged both...

2013-09-23 23:32:49

Immunitor company announces publication of a successful clinical trial in 43 patients with tuberculosis who were given daily pill of therapeutic vaccine containing heat-killed Mycobacterium vaccae. The study, which is the first installment of two-part study, was published in September issue of Human Vaccines & Immunotherapeutics journal. Vancouver, BC, Canada (PRWEB) September 23, 2013 One-month Phase II trial was conducted in sputum smear-positive patients with pulmonary tuberculosis...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.